Benzinga | May 17, 2021 04:35PM EDT

Vivos Therapeutics Q1 EPS $(0.19) Up From $(0.23) YoY, Sales $3.40M Up From $3.20M YoY

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.19) per share. This is a 17.39 percent increase over losses of $(0.23) per share from the same period last year. The company reported $3.40 million in sales this quarter. This is a 6.25 percent increase over sales of $3.20 million the same period last year.